Company intelligence / Profile preview

Puleva Biotech

Ownership: Private
Employees: ~130
Development stage: Other

Overview

Puleva Biotech developed multiple patented functional ingredients—especially probiotics from human milk—and commercialized them through food/dairy industry partners. Clinical studies include safety assessments of specific probiotic strains in infants. The company was a European leader in R&D of functional foods before being acquired/rebranded as Biosearch.

Therapeutic areas: NeurologyEndocrinologyImmunologyRheumatologyCardiovascular
Modalities: ProbioticsLipidsNatural extractsSmall moleculeRecombinant protein
Industry: Non-Drug Biotech

Partnerships

Collaborated with over fifty universities/institutions/hospitals internationallyEbro Foods/Puleva Food S.L.Azucarera Ebro (prebiotic ingredients)Dairy industry partners

Beyond the preview

Go deeper on Puleva Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Puleva Biotech.

Explore the full profile